DexCom (DXCM) PT Raised to $125 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
DexCom (DXCM) PT Raised to $130 at Morgan Stanley
August 3, 2018 7:46 AM EDTMorgan Stanley raised its price target on DexCom (NASDAQ: DXCM) to $130.00 (from $70.00) while maintaining a Equalweight rating.
... MoreDexCom (DXCM) PT Raised to $125 at BMO Capital
August 2, 2018 8:58 AM EDTBMO Capital raised its price target on DexCom (NASDAQ: DXCM) to $125.00 (from $112.00) while maintaining a Outperform rating.
... MoreDexCom (DXCM) PT Raised to $120 at Cowen Following 'Monster' Qtr
August 2, 2018 7:59 AM EDTCowen raised its price target on DexCom (NASDAQ: DXCM) to $120.00 (from $110.00) while maintaining a Outperform rating following its "huge" beat and raise.
Analyst Doug Schenkel commented, "DXCM posted a huge beat and raise. Deals with payers to expand access / simplify distribution could temper... More
DexCom (DXCM) PT Raised to $125 at Jefferies
August 2, 2018 5:14 AM EDTJefferies raised its price target on DexCom (NASDAQ: DXCM) to $125.00 (from $115.00) while maintaining a Buy rating.
... MoreDexCom (DXCM) Tops Q2 EPS by 8c
August 1, 2018 5:04 PM EDTDexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.10), $0.08 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $242.5 million versus the consensus estimate of $205.68 million.
GUIDANCE:
DexCom sees FY2018 revenue of $925 million, versus the consensus of $862.2 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
... More